|
|
|
Congressional Testimony
|
|
|
|
|
|
|
|
|
|
1997
September
- Fred Shank, Ph.D.,
September 25, 1997
Director, Center for
Food Safety and Applied Nutrition, Food and Drug Administration,
Subcommittee on Human Resources on the potential human health
threats that may be posed by Pfiesteria via human consumption
of seafood.
- Dr. Thomas Shope, September
25, 1997
Acting Director, Division of Electronics and Computer Science before
the subcommittee on Oversight and Investigations, Committee on Veteran's
Affairs, U.S. House of Representative on "Year 2000" date
issue as it related to medical devices.
July
- Dr. Kathryn C. Zoon, July
31, 1997
Director, Center for Biologics Evaluation and Research, FDA,
before the Subcommittee on Human Resources and Intergovernmental
Relations. Safety implications of plasma pool sizes in the
manufacture of fractionated blood products.
- Dr. Murray M. Lumpkin,
July 30, 1997
Deputy Director for Review Management, Center for Drug Evaluation and
Research, FDA, DHHS, before the Subcommittee on Health and Environment,
Committee on Commerce, U.S. House of Representatives on the implementation
of Title VI of the Clean Air Act.
June
- Dr. Thomas Shope, June
26, 1997
Acting Director, Division of Electronics and Computer Science
before the subcommittee on Oversight and Investigations,
Committee on Veteran's Affairs, U.S. House of Representative
on "Year 2000" date
issue as it related to medical devices.
- Dr. Michael A. Friedman,
June 5, 1997
Lead Deputy Commissioner of Food and Drug Administration before the
Subcommittee on Human Resources and Intergovernmental relations U.S.
House of Representatives on FDA's role in regulating and protecting
the nation's blood supply.
May
- Mary K. Pendergast,
May 8, 1997
Deputy Commissioner and Senior Advisor
to the Commissioner of Food and Drugs, before the subcommittee
on human resources to discuss the Agency's policies with
respect to the protection of human subjects in biomedical
research.
April
- Dr. Michael A. Friedman,
April 30, 1997
Lead Deputy Commissioner, Food and Drug Administration before
the Subcommittee on Health and The Environment on Reauthorization
of the FDA's Medical Device Program.
- Dr. Michael A. Friedman,
April 23, 1997
Food and Drug Administration before the Subcommittee on Health and The
Environment on Reauthorization of the Prescription Drug User Fee Act
of 1992.
March
- Dr. Michael A. Friedman,
March 19, 1997
Deputy Commissioner for Operations, Food and Drug Administration before
the Committee on Labor and Human Resources on FDA's Accomplishments
and Proposals.
February
- William B. Schultz, February
6, 1997
Deputy Commissioner for Policy, Food and Drug Administration, before
the Subcommittee on Oversight and Investigations on FDA's regulation
of products that can be used in the home and in other nonprofessional
settings (over-the-counter (OTC))to test for drugs of abuse.
January
- Dr. Michael A.
Friedman, January 29, 1997
Deputy Commissioner for Operations, Food and Drug Administration, Committee
on Government Reform and Oversight to discuss proposed rule on the ruminant
to ruminant feed ban and the potential transmission of spongiform encephalopathies
to humans.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|